University of South Carolina, Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, Columbia, SC, USA.
Emory University, Doctoral Program in Nutrition and Health Sciences, Laney Graduate School, Atlanta, GA, USA.
J Nutr. 2021 Feb 15;151(Suppl 1):15S-28S. doi: 10.1093/jn/nxaa192.
Anemia, iron deficiency, and iodine deficiency are problems of important public health concern in many parts of the world, with consequences for the health, development, and work capacity of populations. Several countries are beginning to implement double fortified salt (DFS) programs to simultaneously address iodine and iron deficiencies.
Our objective was to summarize the evidence for efficacy and effectiveness of DFS on the full range of status and functional outcomes and across different implementation and evaluation designs essential to successful interventions.
We conducted a systematic review and meta-analysis of published and gray literature examining the effects of DFS on nutritional status, cognition, work productivity, development, and morbidity of all population groups. We searched for articles in Medline, Embase, CINAHL, Cochrane Central Register, and ProQuest for randomized trials, quasi-randomized trials, and program effectiveness evaluations.
A total of 22 studies (N individuals = 52,758) were included. Efficacy studies indicated a significant overall positive effect on hemoglobin concentration [standardized mean difference (95% CI): 0.33 (0.18, 0.48)], ferritin [0.42 (0.08, 0.76)], anemia [risk ratio (95% CI): 0.80 (0.70, 0.92)], and iron deficiency anemia [0.36 (0.24, 0.55)]. Effects on urinary iodine concentration were not significantly different between DFS and iodized salt. The impact on functional outcomes was mixed. Only 2 effectiveness studies were identified. They reported programmatic challenges including low coverage, suboptimal DFS quality, and storage constraints.
Given the biological benefits of DFS across several populations in efficacy research, additional evaluations of robust DFS programs delivered at scale, which consider effective implementation and measure appropriate biomarkers, are needed.
在世界许多地区,贫血、缺铁和缺碘都是重要的公共卫生问题,对人群的健康、发育和工作能力都有影响。一些国家开始实施强化盐(DFS)项目,以同时解决碘和铁缺乏问题。
我们旨在总结 DFS 在各种状态和功能结果方面的有效性和效果的证据,以及成功干预所必需的不同实施和评估设计。
我们对已发表和灰色文献进行了系统回顾和荟萃分析,以研究 DFS 对所有人群营养状况、认知、工作生产力、发育和发病率的影响。我们在 Medline、Embase、CINAHL、Cochrane 中央注册和 ProQuest 中搜索了关于随机试验、准随机试验和方案效果评估的文章。
共纳入 22 项研究(N 个体=52758)。疗效研究表明,血红蛋白浓度[标准化均数差(95%可信区间):0.33(0.18,0.48)]、铁蛋白[0.42(0.08,0.76)]、贫血[风险比(95%可信区间):0.80(0.70,0.92)]和缺铁性贫血[0.36(0.24,0.55)]均有显著的整体阳性效应。DFS 和碘盐在尿碘浓度上的影响没有显著差异。对功能结果的影响则各不相同。仅确定了 2 项效果研究。它们报告了项目挑战,包括覆盖率低、DFS 质量不理想和储存限制。
鉴于在疗效研究中 DFS 对多个人群的生物学益处,需要进一步评估在大规模上实施的稳健 DFS 方案,并考虑有效的实施和衡量适当的生物标志物。